Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11771748 Methods for treating tumor-induced osteomalacia

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Tomohiro Sudo

Javier San Martin

Emil D. Kakkis

Date of Patent

October 3, 2023

Patent Application Number

17525738

Date Filed

November 12, 2021

Patent Citations

US Patent 7745406 Fibroblast growth factor (FGF23) polypeptides

US Patent 7883705 Anti FGF23 antibody and a pharmaceutical composition comprising the same

US Patent 7923012 Antibody against fibroblast growth factor-23

US Patent 7947810 Kits for diagnosing a hypophosphatemic disorder

US Patent 7981419 Method for treating hypophosphatemic bone diseases using FGF-23 antibody

US Patent 8586317 Methods of diagnosing hypophosphatemic disorders

US Patent 8889426 Methods of identifying inhibitors of FGF23 binding to the binary FGFR-klotho complex for the treatment of hypophosphatemia

US Patent 8889621 Inhibiting binding of FGF23 to the binary FGFR-Klotho complex for the treatment of hypophosphatemia

...

Patent Primary Examiner

Christine J. Saoud

Patent abstract

The present invention provides compositions and methods for treating tumor-induced osteomalacia. The method entails administering to a subject a pharmaceutical composition containing an anti-FGF23 ligand, wherein the dosing regimen of the pharmaceutical is designed to reach effective and efficient control of FGF23 activity.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11771748 Methods for treating tumor-induced osteomalacia

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.